Abstract-Background, Motivation and Objective: We have previously presented a method of ultrasound image guidance known as a dual-mode ultrasound array (DMUA). A DMUA uses the same elements for imaging and therapy creating an inherent registration between the two modalities and allowing for precise HIFU targeting. Previous results have demonstrated the abilities of DMUAs on phantoms and in vitro tissues with offline data processing, here we present in vivo results from a fully functional, real-time implementation of a DMUA.
I. INTRODUCTION
There has long been a recognition in the value of using therapeutic elements beyond their traditional CW transmit mode and into a pulsed transmit/receive mode. This dual use of the therapeutic elements has allowed for new forms of guidance, monitoring and control [1] - [8] . One embodiment of this paradigm is a so-called dual-mode ultrasound array (DMUA). A DMUA uses its array of therapeutic elements not only to deliver targeted high-intensity focused ultrasound (HIFU) but also to create ultrasound images of the therapeutic focal region. The use of the same elements for imaging and therapy eliminates registration errors between the guidance and therapy coordinate systems giving this form of feedback great utility. In addition, the imaging pulses interrogate the exact same medium as the therapeutic bursts allowing for robust recognition of potential obstructions to the HIFU beam.
The DMUAs unique size, shape, and mode of combined imaging and therapy prevents the direct connection to a conventional diagnostic imaging system. To date, most DMUA validation studies have relied on offline data acquisition and processing to demonstrate results. These early results showed the potential of the DMUA concept but limited their studies to phantom and in vitro targets. This paper describes one of the first real-time DMUA system and the results of the initial in vivo studies enabled by this unique therapy and imaging system. First, a brief system overview is presented with focus on aspects unique to the DMUA platform. Second, the results from two animal studies conducted in rat and swine models are presented. These studies demonstrate the ability of a DMUA to create anatomically correct images for use in precise HIFU guidance and monitoring.
II. MATERIALS AND METHODS
A DMUA system is enabled by both the array and the transmit/receive system driving the array. The array must have elements whose bandwidth is wide enough to enable short duration imaging pulses, but are also efficient enough to convey HIFU levels of acoustic power. The transmit system must be capable of interleaving therapy bursts with imaging pulses at high speeds while the receive system must be capable of simultaneous data acquisition on all elements. The final piece of the system consists of a beamformer to process the rf data and present a B-mode image to the user in real-time for immediate feedback.
A. Dual Mode Ultrasound Array
Piezocomposite transducer technology (Imasonic, Voray sur l'Ognon, France) was used for manufacturing a customdesigned DMUA transducer for use in small-animal experiments as well as peripheral vascular applications.. The array consists of two rows of 32, 
B. System Driver and Receiver
The continuous wave synthesis method, described in [9] , is used to calculate the phases and amplitudes required to generate a desired pressure field. This synthesis technique, which requires the multiplication and inversion of several low order matrices, is carried out on a core i7 processor with Intel's Math Kernel Library and requires less than 1 ms processing time. Update rates of this magnitude provide the ability for extremely precise spatiotemporal control of the therapy process [10] .
The calculated amplitudes and phases are conveyed to the array through a 32 channel, FPGA based, arbitrary waveform generator. Commands and data are transmitted to the waveform generators through a gigabit ethernet connection ensuring a low latency, high-bandwidth communication link. Each channel has a dedicated 10-bit DAC (DAC5652, Texas Instruments, Dallas, Texas) which generates a signal that is fed through a custom-built 10 Watt linear amplifier, a high power matching network, and delivered to the array through a micro-coaxial cable. This setup allows the array to create focal intensities in the range of 5,000 -12,000 W/cm 2 (in water), which is suitable for lesion formation in tissues at depths 0.6 -2.3 cm.
Each element on the array has an independent receiver and signal processing chain. Echo data from each element is passed through a software controllable analog front end (AFE) before being digitized by a 12 bit, 50 MSPS ADC (AFE5801, Texas Instruments, Dallas, Texas). The AFE allows dynamic control over the filtering and scaling of the analog signal to ensure the full dynamic range of the ADC is utilized without causing saturation. This control is crucial for monitoring tissue during HIFU therapies where dramatic changes in echogenicity can cause the strength of the received echo signal to vary by orders of magnitude.
The 32 channels of digitized echo data are processed by two FPGAs (Virtex 5, Xilinx, San Jose, CA). The FPGAs work in parallel to pass the data through a reconfigurable 208 tap FIR filter and an optional 4x decimator before buffering the data in on-chip memory. The reconfigurable filter gives a wide degree of latitude in how the signals are processed without introducing additional processing delays (beyond the group delay of the filter). For instance, the filter can be configured as a bandpass filter to highlight harmonic signal components. Alternatively, the filter can represent a matched filter or pseudoinverse filter to allow for coded excitation imaging.
C. Beamformer
The data received from the FPGAs through the gigabit ethernet is transferred to a GPU (GTX 285, NVIDIA, Santa Clara, CA) where massively parallel processing allows for additional filtering, beamforming, envelope detection, and log compression to take place in real-time. The processing times for the individual steps is shown in Table I for both STF and SA imaging.
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III. RESULTS AND DISCUSSION
The DMUA system described above has been used on a variety of in vitro and in vivo targets. The results presented below focus on a series of experiments which used the DMUA platform to target the wall of the femoral artery in swine. During therapy, the animal was positioned in a supine posture with a water bath positioned above the intended treatment spot (as identified by pretreatment angiography and diagnostic ultrasound scanning). The care of the animal was monitored by trained technicians in accordance with an approved animal care protocol VSP001 (American Preclinical Services, Coon Rapids, MN).
A. Vessel Identification and Targeting
Pretreatment diagnostic ultrasound scans were compared with online DMUA SA imaging to aid in the proper identification of the intended treatment site. An example of this comparison is shown in Figure 2 . Once the DMUA was aligned in the approximate treatment location, the SA image based feedback allowed for submillimeter targeting using electronic phased array steering. An example of the DMUA imaging is shown in Figure 3 where a 5mm spaced grid is overlaid on the DMUA image (intersection of red lines represents the geometric focus). The positioning of the array placed the geometric focus slightly below the artery and in the proximal section of the vein. This image based feedback allowed the HIFU focus (represented by the green crosshairs) to be steered to the artery wall. The inherent alignment between the DMUA imaging and therapeutic coordinates ensured that this correction, though small, was accurate. Histological sectioning of the targeted vessels confirmed the localization of the damage to the wall of the targeted arteries. As shown in Figure 4 , the damage pattern appears to spare the tunica intima with the damage confined to the tunica media and surrounding tissue. This is most likely due to both the accurate placement of the HIFU focus and the cooling effect of the blood in the artery. 
IV. CONCLUSIONS
The system presented here represents a complete extracorporeal ultrasound-guided focused ultrasound surgery platform. A single array was used to both deliver HIFU therapy and provide image based feedback. The imaging and therapy was enabled by a unique platform which relies on highperformance CPUs, GPUs and FPGAs to perform the calculations and signal processing necessary to operate the DMUA in real-time. The system provided image based feedback allowing the precise targeting of the HIFU therapy with sub-millimeter resolution.
The results presented above demonstrate the DMUAs ability to accurately target and ablate in vivo tissues. The DMUA was used to target peripheral vascular structures in swine, specifically the wall of the femoral artery. The images created by the DMUA proved suitable for guidance and localization enabling accurately directed HIFU therapy. Histology confirmed the localization of the tissue damage to the vessel wall, sparing the innermost layers of tissue directly adjacent to the flowing blood. These early, promising results lead to a study currently in progress investigating the effects of DMUA applied HIFU on atheroscleratic plaques.
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